European Journal of Epidemiology

, Volume 16, Issue 11, pp 1069–1072

Seroprevalence of hepatitis A, B and C markers in Greek warship personnel

  • E. Mazokopakis
  • J. Vlachonikolis
  • A. Philalithis
  • C. Lionis
Article

Abstract

A seroepidemiological study was conducted to assess the seroprevalence of hepatitis A, B and C markers in 285 males (mean age: 24.4 ± 4.4 years) aboard a Greek warship. Two hundred and sixty three serum samples were tested. None was found to be positive for HAV antibodies, three persons (1.1%) were positive for HBsAg, four persons (1.5%) were positive for anti-HBc and one person (0.4%) was positive for anti-HCV. Forty-five persons (17.1%) had developed titles anti-HBs >10 IU/L. The establishment of a vaccination policy against hepatitis A among warship personnel is strongly recommended.

Greece Hepatitis A Hepatitis B Hepatitis C Military personnel Risk factors Seroprevalence Warship 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hooper RR, Cunnion SO, Conwill DE, Merrell BR, Wallace JG, Batchelor RA. Hepatitis A and B in a naval population. Mil Med 1988; 153: 350–355.Google Scholar
  2. 2.
    Malone JD, Hyams KC, Hawkins RE, Sharp TW, Daniell FD. Risk factors for sexually-transmitted diseases among deployed U.S. military personnel. Sex Transm Dis 1993; 20: 294–298.Google Scholar
  3. 3.
    Papaevangelou G, Totos Gr, Roumeliotou A, Safary A. Brief report: Hepatitis A vaccination in Greek military recruits. J Med Virol 1993; 40: 1–4.Google Scholar
  4. 4.
    Papaevangelou G. Hepatitis B immunization programme: Lessons learnt in Greece. Vaccine 1998; 16(Suppl): 45–47.Google Scholar
  5. 5.
    Moschen ME, Floreani A, Zamparo E, et al. Hepatitis A infection: A seroepidemiological study in young adults in North-East Italy. Eur J Epidemiol 1997; 13: 875–878.Google Scholar
  6. 6.
    Dal-Re R, Garcia-Corbeira P, Garcia-de-Lomas J. A large percentage of the Spanish population under 30 years of age is not protected against hepatitis A. J Med Virol 2000; 60: 363–366.Google Scholar
  7. 7.
    Papaevangelou G. Epidemiology of hepatitis A in Mediterranean countries. Vaccine 1992; 10(Suppl): 63–66.Google Scholar
  8. 8.
    Frosner GG, Papaevangelou G, Butler R, et al. Antibody against hepatitis A in seven European Countries. I. Comparison of prevalence data in different age groups. Am J Epidemiol 1979; 110: 63–69.Google Scholar
  9. 9.
    Lionis C, Frangoulis E, Koulentakis M, Biziagos E, Kouroumalis E. Prevalence of hepatitis A, B, and C markers in school children of a rural area of Crete, Greece. Eur J Epidemiol 1997; 3: 417–420.Google Scholar
  10. 10.
    Lionis C, Koulentakis M, Biziagos E, Kouroumalis E. Current prevalence of hepatitis A, B, and C in a well — defined area in rural Crete, Greece. J Viral Hepat 1997; 4: 55–61.Google Scholar
  11. 11.
    Kremastinou J, Kalapothaki V, Trichopoulos D. The changing epidemiologic pattern of hepatitis A infection in urban Greece. Am J Epidemiol 1984; 120: 703–706.Google Scholar
  12. 12.
    Papaevangelou G, Roumeliotou-Karayannis A, Contoyannis P. Changing epidemiological characteristics of acute viral hepatitis in Greece. Infection 1982; 10: 1–4.Google Scholar
  13. 13.
    Koff RS. Hepatitis A. Lancet 1998; 351: 1643–1649.Google Scholar
  14. 14.
    Hawkins RE, Malone JD, Cloninger LA, et al. Risk of viral hepatitis among military personnel assigned to US Navy ships. J Infect Dis 1992; 165: 716–719.Google Scholar
  15. 15.
    Tassopoulos NC, Papatheodoridis GV. Epidemiology of hepatitis B virus infection. Hellenic J Gastroenterol 1993; 6: 67–73.Google Scholar
  16. 16.
    Papatheodoridis GV, Tassopoulos NC. The natural history of hepatitis B virus infection. Arch Hellen Med 1997; 14: 138–147 (in Greek, abstract in English).Google Scholar
  17. 17.
    Hadziyannis S. Blood donors screening for antibodies to the hepatitis C virus. Five contemporary issues. Iatriki 1992; 61: 98–103 (in Greek, abstract in English).Google Scholar
  18. 18.
    Hadziyannis SJ, Giannoulis G, Hadziyannis E, Alexopoulou A, Dourakis S, Trichopoulos D. Hepatitis C virus infection in Greece and its role in chronic liver disease and hepatocellular carcinoma. J Hepatol 1993; 17(Suppl): 572–577.Google Scholar
  19. 19.
    Papatheodoridis GV, Tassopoulos NC. Epidemiology of hepatitis B virus. Iatriki 1993; 64: 504–512 (in Greek, abstract in English).Google Scholar
  20. 20.
    Dourakis SP. Hepatitis C virus. Arch Hellen Med 1994; 11(Suppl) A43-A84 (in Greek, abstract in English).Google Scholar

Copyright information

© Kluwer Academic Publishers 2000

Authors and Affiliations

  • E. Mazokopakis
    • 1
    • 2
  • J. Vlachonikolis
    • 3
  • A. Philalithis
    • 4
  • C. Lionis
    • 2
  1. 1.Clinic of Internal MedicineNaval Hospital of AthensGreece
  2. 2.University of CreteGreece
  3. 3.Laboratory of BiostatisticsGreece
  4. 4.Laboratory of Health Services, Department of Social Medicine, School of MedicineUniversity of CreteGreece

Personalised recommendations